KZA 0.00% 8.0¢ kazia therapeutics limited

BLT SP, page-17

  1. 1,709 Posts.
    lightbulb Created with Sketch. 644
    Absolutely correct Plough. Then consider the costs of administering this company that is producing little revenue of any consequence. What is there to administer other than the research team?
    I am very pleased to see funds being directed to costs which support the company purpose and objectives. When the cost of administration is greater than the actual R & D spend, questions should be asked of directors, please explain.
    When the directors put their hand out for more, to me this explains the lack of financial control being exercised by those elected to govern the business.
    Vote no to all three resolutions. Performance first before reward.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.